Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity.

Sengupta P, Basu S, Soni S, Pandey A, Roy B, Oh MS, Chin KT, Paraskar AS, Sarangi S, Connor Y, Sabbisetti VS, Kopparam J, Kulkarni A, Muto K, Amarasiriwardena C, Jayawardene I, Lupoli N, Dinulescu DM, Bonventre JV, Mashelkar RA, Sengupta S.

Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11294-9. doi: 10.1073/pnas.1203129109. Epub 2012 Jun 25.

2.

Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.

Hadinoto K, Sundaresan A, Cheow WS.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17. Review.

PMID:
23872180
3.
4.

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Johnstone TC, Suntharalingam K, Lippard SJ.

Chem Rev. 2016 Mar 9;116(5):3436-86. doi: 10.1021/acs.chemrev.5b00597. Epub 2016 Feb 11. Review.

5.

Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking.

Xue X, Hall MD, Zhang Q, Wang PC, Gottesman MM, Liang XJ.

ACS Nano. 2013 Dec 23;7(12):10452-64. doi: 10.1021/nn405004f. Epub 2013 Dec 10. Review.

7.

Nanocapsules of platinum anticancer drugs: development towards therapeutic use.

Bryde S, de Kroon AI.

Future Med Chem. 2009 Nov;1(8):1467-80. doi: 10.4155/fmc.09.112. Review.

PMID:
21426060
8.

Cisplatin Properties in a Nanobiotechnological Approach to Cancer: A Mini-Review.

Marcato PD, Fávaro WJ, Durán N.

Curr Cancer Drug Targets. 2014;14(5):458-76. Review.

PMID:
24806969
9.
10.

Improving platinum(II)-based anticancer drug delivery using cucurbit[n]urils.

Wheate NJ.

J Inorg Biochem. 2008 Dec;102(12):2060-6. doi: 10.1016/j.jinorgbio.2008.06.005. Epub 2008 Jun 20. Review.

PMID:
18653238
11.

Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma.

Roberts NB, Wadajkar AS, Winkles JA, Davila E, Kim AJ, Woodworth GF.

Oncoimmunology. 2016 Aug 19;5(9):e1208876. eCollection 2016. Review.

PMID:
27757301

Supplemental Content

Support Center